Abstract
We evaluated the possible anticancer performance of a natural compound, goniothalamin (GTN), against human lung cancer using as a non-small cell lung cancer (NSCLC) cell line, H1299, as the model system. Cellular proliferation was significantly inhibited by GTN. Using an improved alkaline comet-nuclear extract (comet-NE) assay, GTN was found to induce a significant increase in the tail DNA. Wound healing and zymography assays showed that GTN attenuated cell migration and caused a reduction in the activity level of two major migration-associated matrix metalloproteinases, MMP-2 and MMP-9. It can be concluded that the DNA-damaging effect of GTN against lung cancer cells leads to growth inhibition as well as a depression in migration ability. Therefore, GTN has potential as a chemotherapeutic agent against lung cancer.
Original language | English |
---|---|
Pages (from-to) | 4288-4293 |
Number of pages | 6 |
Journal | Journal of Agricultural and Food Chemistry |
Volume | 59 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2011 Apr 27 |
Keywords
- Goniothalamin
- cell migration
- comet assay
- matrix metalloproteinase
- non-small cell lung cancer
ASJC Scopus subject areas
- General Chemistry
- General Agricultural and Biological Sciences